欢迎来到天天文库
浏览记录
ID:36615804
大小:855.15 KB
页数:43页
时间:2019-05-13
《卡维地洛治疗老年慢性充血性心力衰竭的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、南京医科大学硕士学位论文卡维地洛治疗老年慢性充血性心力衰竭的临床研究姓名:李拥军申请学位级别:硕士专业:老年心血管指导教师:周秀娟;程蕴琳20030515南京医科夫学碗1擘位论直_第一部分、论文部分中文摘要卡维地洛治疗老年慢性充血性心力衰竭的临床研究f摘要】目的观察卡维地洛治疗老年慢性心力衰竭(心衰)的疗效和安全性。方法选取2001年8月一2002年“月来我院住院的符合入选标准的老年(>165岁)慢性充血性心衰患者45例,随机分为卡维地洛组23例(实验组)和对照组22例,两组均予心衰常规治疗,在此基础上实验组加用一g-维地洛。卡维地洛由小剂量开始,逐渐递增至
2、最大耐受量。疗程6个月,观察两组治疗前后症状、体征、超声心动图、6分钟步行试验∞变化,,1:检查肝功、肾功、空腹血糖、血常厂·规《。(结果实验结束,两组的左室短轴缩短率(FS)、左室射血分数\(LVEF)较治疗前均有增加,实验组由(22.3l±5.08)%、(39.12±5.24)%,增至(29.10+6.23)%、(49.99±9.48)%(p3、验组由治疗前(351.36+61.29)米增至治疗后(401,94±65.82)米,对照组出治疗前(342.06+-54.84)米增至治疗后(358.80.'一南京饫科夫擎顿:1:学位论文±58.07)米(p4、重J结论在心衰常规治疗基础上加用卡维地洛治疗老年中重度慢性心衰患者耐受量小,但安全、有效。【关键词1心力衰竭,充血性;‘}维地洛:超声心动描记术.塑塞堡型查兰塑兰兰篁堡兰二、英文摘要Theefficacyofcarvediioiinchroniccongestiveheartfailuretreatmentintheelderly【AbstractJ0bjectiveToevaluatetheefficacyofcarvedilolinchronicheartfailure(CHF)treatmentintheelderly.MethodsFromAugus5、t2001toNovember2002,aIotalof450ldpatients(>一/65y)wereenrolledwhoseLVejectionfraction(LVEF)bellowing45%underwentstandardtherapyofCHF.23wereassignedtocarvedilolgroupand22tOcontrolgroup;Carvedilolweretitratedfromlowdosetothetargetdoseormaximaltolerancedoseinadditiontostandardtherapyin6、carvedIlolgroup;Standardtherapyweremerelygivenincontrolgroup.Allpatientswereexaminedwithechocardiography,6-minutewalktest,liverfunctiontests,renalfunctiontest,serumglucosetestandfullbloodcountetc.threetimeswithinsixmonthstoassessleftventricular(LV)function,exercisecapacityandtheeff7、ectontheotherssystems.ResultsComparedwiththebeginningofthestudy,FS,LVEFsignificantlyincreasedinbothgroupsby(22.3t±5.08)%、(39.12+_5,24)%to(29.tO±6.23)%、(49.99南京医科大学颂.L学位论义±9.48)%respectivelyincarvedilolgroupand(23.06±7,13)%、(39.79+--6.70)%to(24.12±7.22>%、(4I.76±6.70)%respectivelyinp8、lacebogroup(p<0.001)atthee
3、验组由治疗前(351.36+61.29)米增至治疗后(401,94±65.82)米,对照组出治疗前(342.06+-54.84)米增至治疗后(358.80.'一南京饫科夫擎顿:1:学位论文±58.07)米(p4、重J结论在心衰常规治疗基础上加用卡维地洛治疗老年中重度慢性心衰患者耐受量小,但安全、有效。【关键词1心力衰竭,充血性;‘}维地洛:超声心动描记术.塑塞堡型查兰塑兰兰篁堡兰二、英文摘要Theefficacyofcarvediioiinchroniccongestiveheartfailuretreatmentintheelderly【AbstractJ0bjectiveToevaluatetheefficacyofcarvedilolinchronicheartfailure(CHF)treatmentintheelderly.MethodsFromAugus5、t2001toNovember2002,aIotalof450ldpatients(>一/65y)wereenrolledwhoseLVejectionfraction(LVEF)bellowing45%underwentstandardtherapyofCHF.23wereassignedtocarvedilolgroupand22tOcontrolgroup;Carvedilolweretitratedfromlowdosetothetargetdoseormaximaltolerancedoseinadditiontostandardtherapyin6、carvedIlolgroup;Standardtherapyweremerelygivenincontrolgroup.Allpatientswereexaminedwithechocardiography,6-minutewalktest,liverfunctiontests,renalfunctiontest,serumglucosetestandfullbloodcountetc.threetimeswithinsixmonthstoassessleftventricular(LV)function,exercisecapacityandtheeff7、ectontheotherssystems.ResultsComparedwiththebeginningofthestudy,FS,LVEFsignificantlyincreasedinbothgroupsby(22.3t±5.08)%、(39.12+_5,24)%to(29.tO±6.23)%、(49.99南京医科大学颂.L学位论义±9.48)%respectivelyincarvedilolgroupand(23.06±7,13)%、(39.79+--6.70)%to(24.12±7.22>%、(4I.76±6.70)%respectivelyinp8、lacebogroup(p<0.001)atthee
4、重J结论在心衰常规治疗基础上加用卡维地洛治疗老年中重度慢性心衰患者耐受量小,但安全、有效。【关键词1心力衰竭,充血性;‘}维地洛:超声心动描记术.塑塞堡型查兰塑兰兰篁堡兰二、英文摘要Theefficacyofcarvediioiinchroniccongestiveheartfailuretreatmentintheelderly【AbstractJ0bjectiveToevaluatetheefficacyofcarvedilolinchronicheartfailure(CHF)treatmentintheelderly.MethodsFromAugus
5、t2001toNovember2002,aIotalof450ldpatients(>一/65y)wereenrolledwhoseLVejectionfraction(LVEF)bellowing45%underwentstandardtherapyofCHF.23wereassignedtocarvedilolgroupand22tOcontrolgroup;Carvedilolweretitratedfromlowdosetothetargetdoseormaximaltolerancedoseinadditiontostandardtherapyin
6、carvedIlolgroup;Standardtherapyweremerelygivenincontrolgroup.Allpatientswereexaminedwithechocardiography,6-minutewalktest,liverfunctiontests,renalfunctiontest,serumglucosetestandfullbloodcountetc.threetimeswithinsixmonthstoassessleftventricular(LV)function,exercisecapacityandtheeff
7、ectontheotherssystems.ResultsComparedwiththebeginningofthestudy,FS,LVEFsignificantlyincreasedinbothgroupsby(22.3t±5.08)%、(39.12+_5,24)%to(29.tO±6.23)%、(49.99南京医科大学颂.L学位论义±9.48)%respectivelyincarvedilolgroupand(23.06±7,13)%、(39.79+--6.70)%to(24.12±7.22>%、(4I.76±6.70)%respectivelyinp
8、lacebogroup(p<0.001)atthee
此文档下载收益归作者所有